Profiles of HBV DNA in a large population of Chinese patients with chronic hepatitis B: Implications for antiviral therapy

Journal of Hepatology

Volumn 54, Issue 2, 2011, Pages 195-200

  Fung, James ^a   Seto, Wai Kay ^a   Lai, Ching Lung ^a   Yuen, John ^a   Wong, Danny Ka Ho ^a   Yuen, Man Fung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Antiviral therapy; Chronic hepatitis B; HBV DNA; Treatment guidelines; Viral load

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CANCER RISK; CHINESE; CHRONIC HEPATITIS; CLINICAL PRACTICE; FEMALE; HEPATITIS B; HUMAN; LIVER BIOPSY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT INDICATION; VIRUS HEPATITIS; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; CHINA; DNA, VIRAL; FEMALE; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; VIRAL LOAD;

EID: 78751578866     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.06.031     Document Type: Article

References (19)

1. W. Lee Hepatitis B virus infection N Engl J Med 337 1997 1733 1745
2. H.I. Yang, S.N. Lu, and Y.F. Liaw Hepatitis B e antigen and the risk of hepatocellular carcinoma N Engl J Med 347 2002 168 174
3. M.F. Yuen, Y. Tanaka, and M. Mizokami Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: a case control study Carcinogenesis 25 2004 1593 1598
4. M.F. Yuen, Y. Tanaka, and N. Shinkai Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels Gut 57 2008 98 102
5. 4 copies/ml is associated with significant risk of hepatocellular carcinoma in chronic hepatitis B patients: An update from the R.E.V.E.A.L. HBV study Hepatology 46 2007 640A
6. C.J. Chen, H.I. Yang, and J. Su Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level JAMA 295 2006 65 73
7. G. Chen, W. Lin, and F. Shen Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study Am J Gastroenterol 101 2006 1797 1803
8. J. Fung, M.F. Yuen, J.C. Yuen, D.K. Wong, and C.L. Lai Low serum HBV DNA levels and development of hepatocellular carcinoma in patients with chronic hepatitis B: a case-control study Aliment Pharmacol Ther 26 2007 377 382
9. A.S. Lok, and B.J. McMahon Chronic hepatitis B Hepatology 50 2009 661 662
10. Liver EAftSot EASL clinical practice guidelines: management of chronic hepatitis B J Hepatol 2009 50 2009 227 242
11. Y.F. Liaw, N. Leung, and J.H. Kao Asian-Pacific consensus statement on the management of chronic hepatitis B Hepatol Int 3 2008 263 283
12. G.V. Papatheodoridis, N. Chrysanthos, E. Hadziyannis, E. Cholongitas, and E.K. Manesis Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection J Viral Hepat 15 2008 434 441
13. N. Kawabe, S. Hashimoto, and M. Harata The loss of HBeAg without precore mutation results in lower HBV DNA levels and ALT levels in chronic hepatitis B virus infection J Gastroenterol 44 2009 751 756
14. Y.H. Ni, M.H. Chang, and P.J. Chen Viremia profiles in children with chronic hepatitis B virus infection and spontaneous e antigen seroconversion Gastroenterology 132 2007 2340 2345
15. Y.H. Huang, J.C. Wu, and T.T. Chang Association of core promoter/precore mutations and viral load in e antigen-negative chronic hepatitis B patients J Viral Hepat 13 2006 336 342
16. N. Misawa, A. Matsumoto, and E. Tanaka Patients with and without loss of hepatitis B virus DNA after hepatitis B e antigen seroconversion have different virological characteristics J Med Virol 78 2006 68 73
17. M.F. Yuen, E. Sablon, and H.J. Yuan Relationship between the development of precore and core promoter mutations and hepatitis B e antigen seroconversion in patients with chronic hepatitis B virus J Infect Dis 186 2002 1335 1338
18. M.F. Yuen, H.J. Yuan, and D.K. Wong Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications Gut 54 2005 1610 1614
19. M.F. Yuen, Y. Tanaka, and D.Y. Fong Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B J Hepatol 50 2009 80 88